Table 3:
Covariates | Unadjusted OR (95% CI) | p-value | Adjusted OR (95% CI)* | p-value |
---|---|---|---|---|
Age<65 years | 1.02 (1.00–1.05) | 0.10 | 1.21 (1.17–1.25) | <0.001 |
Female sex | 1.10 (1.07–1.13) | <0.001 | 1.09 (1.07–1.12) | <0.001 |
Primary payer | ||||
Medicare | Reference | Reference | ||
Medicaid | 1.15 (1.11–1.20) | <0.001 | 1.05 (1.002–1.10) | 0.04 |
Private insurance | 0.54 (0.52–0.56) | <0.001 | 0.63 (0.60–0.66) | <0.001 |
Self-pay | 0.51 (0.48–0.55) | <0.001 | 0.61 (0.57–0.66) | <0.001 |
No charge | 0.50 (0.42–0.59) | <0.001 | 0.61 (0.51–0.72) | <0.001 |
Other | 0.66 (0.60–0.72) | <0.001 | 0.71 (0.65–0.78) | <0.001 |
Missing | 0.53 (0.35–0.81) | <0.001 | 0.57 (0.37–0.86) | 0.008 |
Income quartile of patient’s ZIP code | ||||
First | Reference | Reference | ||
Second | 0.92 (0.89–0.95) | <0.001 | 0.97 (0.94–1.00) | 0.06 |
Third | 0.88 (0.85–0.91) | <0.001 | 0.95 (0.91–0.99) | 0.007 |
Fourth | 0.83 (0.79–0.87) | <0.001 | 0.93 (0.89–0.97) | 0.002 |
Missing | 0.87 (0.78–0.97) | 0.01 | 0.94 (0.84–1.04) | 0.23 |
Hospital characteristics | ||||
Hospital bedsize | ||||
Small | Reference | Reference | ||
Medium | 1.09 (1.02 – 1.15) | 0.007 | 1.05 (0.99–1.11) | 0.08 |
Large | 1.11 (1.05–1.17) | <0.001 | 1.07 (1.01–1.12) | 0.02 |
Teaching status | ||||
Metropolitan nonteaching | Reference | Reference | ||
Metropolitan teaching | 0.97 (0.93–1.00) | 0.07 | 0.98 (0.95–1.02) | 0.36 |
Nonmetropolitan hospital | 0.89 (0.84–0.95) | <0.001 | 0.94 (0.88–1.00) | 0.054 |
Hospital control | ||||
Government, nonfederal | Reference | Reference | ||
Private, not-for-profit | 1.04 (0.98–1.10) | 0.19 | 1.01 (0.96–1.06) | 0.78 |
Private, investor-owned | 1.14 (1.07–1.22) | <0.001 | 1.10 (1.03–1.16) | 0.003 |
Comorbidities | ||||
DM with complications | 1.64 (1.59–1.70) | <0.001 | 1.20 (1.16–1.24) | <0.001 |
Chronic kidney disease | 1.85 (1.81–1.90) | <0.001 | 1.20 (1.16–1.24) | <0.001 |
End-stage renal disease | 2.21 (2.14–2.29) | <0.001 | 1.46 (1.41–1.52) | <0.001 |
Valvular heart disease | 1.11 (1.05–1.16) | <0.001 | 1.03 (0.98–1.09) | 0.29 |
Obesity | 0.89 (0.86–0.91) | <0.001 | 0.86 (0.83–0.89) | <0.001 |
Peripheral vascular disease | 1.28 (1.24–1.33) | <0.001 | 1.10 (1.06–1.15) | <0.001 |
Chronic lung disease | 1.44 (1.40–1.48) | <0.001 | 1.19 (1.16–1.23) | <0.001 |
Pulmonary circulation disease | 1.37 (1.30–1.45) | <0.001 | 1.09 (1.03–1.16) | 0.003 |
Chronic liver disease | 1.63 (1.52–1.75) | <0.001 | 1.27 (1.18–1.37) | <0.001 |
Coagulopathy | 1.24 (1.18–1.31) | <0.001 | 1.02 (0.97–1.08) | 0.41 |
Drug abuse | 1.37 (1.30–1.44) | <0.001 | 1.32 (1.25–1.40) | <0.001 |
Charlson comorbidity index >3 | 1.93 (1.88–1.98) | <0.001 | 1.25 (1.21–1.29) | <0.001 |
End-organ involvement | ||||
Acute or unspecified heart failure | 1.92 (1.87–1.98) | <0.001 | 1.37 (1.32–1.42) | <0.001 |
Acute myocardial infarction | 0.95 (0.91–0.98) | 0.004 | 1.00 (0.96–1.04) | 0.87 |
Stroke or transient ischemic attack | 0.54 (0.52–0.56) | <0.001 | 0.76 (0.73–0.80) | <0.001 |
Length of stay > median | 1.44 (1.40–1.47) | <0.001 | 1.25 (1.22–1.29) | <0.001 |
Disposition | ||||
Routine | Reference | Reference | ||
Transfer to short-term hospital | 1.48 (1.33–1.64) | <0.001 | 1.60 (1.44–1.78) | <0.001 |
Transfer to skilled nursing facility or intermediate care facility | 1.35 (1.31–1.39) | <0.001 | 1.29 (1.24–1.33) | <0.001 |
Home healthcare | 1.36 (1.32–1.41) | <0.001 | 1.24 (1.20–1.28) | <0.001 |
Discharge against medical advice | 2.44 (2.24–2.66) | <0.001 | 2.20 (2.01–2.40) | <0.001 |
Unknown | 0.31 (0.16–0.61) | <0.001 | 0.34 (0.17–0.68) | 0.002 |
*AIC for full model – AIC for null model= –7404.3, BIC for full model – BIC for null model= –7013.5. Differences in AIC and BIC for full model versus null model indicate very strong support for the full model. Likelihood ratio test showed a statistically significant improvement in model fit (p<0.001) for the full model compared with the null model.
AIC: Akaike Information Criterion, BIC: Bayesian Information Criterion